Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves

Malik, AH; Yandrapalli, S; Aronow, WS; Panza, JA; Cooper, HA

Malik, AH (reprint author), Westchester Med Ctr Hlth Network, Valhalla, NY 10595 USA.

HEART, 2019; 105 (18): 1432

Abstract

Objective Current guidelines endorse the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF). Howeve......

Full Text Link